Discontinuation report TARO-WARFARIN
Report ID | 173760 |
Drug Identification Number | 02242697 |
Brand name | TARO-WARFARIN |
Common or Proper name | WARFARIN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-11-01 |
Remaining supply date | 2022-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-11-04 | French | Compare |
v1 | 2022-11-04 | English | Compare |
Showing 1 to 2 of 2